Hot Insurance Stocks To Own Right Now

Purchase Price1: $20.24 (12/28/2016) Market Capitalization: $1.68 Billion Price Target: $30.36 Enterprise Value: $2.02 Billion Upside: 50% EV/EBITDA: 6.7 Click to enlarge

Syntel Inc. (NASDAQ:SYNT) provides information technology and knowledge process outsourcing (KPO) services. Syntel provides its services to the banking and financial services, healthcare and life sciences, insurance, manufacturing, retail, logistics, and telecom industries. Within those industries, Syntel assists its clients with modernizing their systems, processes, as well as fulfilling their never-ending desire to remain on the cutting edge of the technological wave. The company separates its services into the following categories:

Hot Insurance Stocks To Own Right Now: Duke Energy Corporation(DUK)

Advisors’ Opinion:

  • [By Chris Lange]

    Duke Energy Corp. (NYSE: DUK) shares were up 2.6% at $76.24. The stock has a 52-week range of $72.93 to $91.80 and a consensus price target of $86.13.

  • [By Chris Lange]

    Duke Energy Corp.’s (NYSE: DUK) fourth-quarter results are scheduled for Tuesday. The consensus estimates are calling for $0.92 in earnings per share (EPS) on $6.17 billion in revenue. The shares traded on Friday’s close at $76.70. The consensus price target is $85.67, and the 52-week trading range is $72.93 to $91.80.

  • [By WWW.KIPLINGER.COM]

    Duke Energy Corp. (DUK), the largest generator of electricity in the nation, is awfully steady.

    DUK has more than 7.4 million customers located in hotbeds of growth, and it boasts a generating capacity of 52,697 megawatts. The firm also provides natural gas distribution in many of its main service areas, so Duke is a double threat in that way. Cold winter? Nat gas provides more oomph. Hot summer? Electricity demand spikes.

Hot Insurance Stocks To Own Right Now: Canadian National Railway Company(CNI)

Advisors’ Opinion:

  • [By Brett Hershman]

    The Swiss bank said it was raising first-quarter estimates on four of the six rails it covers, with updated estimates above consensus on Canadian National Railway (USA) (NYSE: CNI), CSX Corporation (NASDAQ: CSX) and Kansas City Southern (NYSE: KSU), which is seen to show upside against low expectations.

  • [By Monica Gerson]

    Canadian National Railway (USA) (NYSE: CNI) is estimated to post its quarterly earnings at $0.92 per share on revenue of $3.08 billion.

    Container Store Group Inc (NYSE: TCS) is expected to post its quarterly earnings at $0.21 per share on revenue of $230.53 million.

  • [By Paul Ausick]

    GE got some good news this past week with an order for 200 locomotives from Canadian National Railway Co. (NYSE: CNI). The locomotives will be built at GE’s plant in Fort Worth, Texas, and deliveries to the rail operator will begin next year. The balance of the locomotives will be delivered in 2019 and 2020.

Hot Insurance Stocks To Own Right Now: Ono Pharmaceutical Co., Ltd. (OPHLF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Merck could achieve a consistent advantage versus BMS in treatment of 1L NSCLC. There is a precise crossroad that will determine the future of these two companies in this field: the question of whether or not Keytruda will be approved in May. Both the market and investors believe that it will indeed gain approval and BMS’s stock is already paying for that. In the short term, the repercussions will be the contractions in the sales of Opdivo in 2L and a bigger obstacle for Opdivo+Yervoy in 1L. But the BMS’s combo can catch up, thanks to a bigger efficacy, as I will explain in a future article. Meanwhile, a recent trial established that Merck has to pay BMS $625M plus royalties, as it infringed BMS’s intellectual property related to the use of anti-PD1 antibodies. The royalties will be 6.5% for sales between January 2017 and the end of 2023, followed by a 2.5% rate for the period from January 2024 to the end of 2026. Bristol-Myers Squibb will share the money by giving a quarter of the amount to the Japanese Ono Pharmaceutical (OTC:OPHLF), the company which had discovered Opdivo.